4//SEC Filing
Kestenberg-Messina Kaitlin M. 4
Accession 0001140361-25-002926
CIK 0001368514other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:00 PM ET
Size
10.1 KB
Accession
0001140361-25-002926
Insider Transaction Report
Form 4
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
Transactions
- Exercise/Conversion
Common Stock
2025-01-30$10.80/sh+5,000$54,000→ 449,587 total - Exercise/Conversion
Employee Stock Option (right to buy)
2025-01-30−5,000→ 0 totalExercise: $10.80Exp: 2025-01-30→ Common Stock (5,000 underlying) - Tax Payment
Common Stock
2025-01-30$16.10/sh−3,355$54,016→ 446,232 total
Footnotes (4)
- [F1]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date.
- [F2]Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;
- [F3](continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 135,162 shares of common stock owned by the reporting person, which reflects the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
- [F4]The option was granted on January 30, 2015 and is fully vested.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeother
Related Parties
1- filerCIK 0002017423
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 9:00 PM ET
- Size
- 10.1 KB